Apparel & Footwear
Search documents
The Hard Part of Nike's Turnaround Is Just Beginning
The Motley Fool· 2026-03-01 01:05
After several difficult years, Nike (NKE 2.77%) has finally stabilized. Revenue declines have moderated. Inventory levels look healthier than they did a year ago. Management has stepped back from its aggressive direct-to-consumer push and rebuilt key wholesale relationships. The slide appears to have stopped. But stopping the decline was the easier task. Rebuilding the earnings profile is far harder. The reset was unavoidable Nike's challenges were structural, not cosmetic. Fiscal year 2025 (ended May 31, 2 ...
Higher Tariffs and Production Costs: Is NIKE Ready to Adapt?
ZACKS· 2026-02-24 15:16
Key Takeaways NKE faces $1.5B in annualized costs from higher U.S. tariffs, pressuring margins.Gross margin fell 300 bps to 40.6% in Q2 FY26 as EPS dropped 32% year over year.NIKE targets efficiency gains to offset tariffs, expecting Q3 margin down 175-225 bps.NIKE, Inc. (NKE) , like other industry players, remains exposed to the impact of rising tariffs and production costs. Management highlighted rising tariffs as a major structural headwind affecting the financial performance and cost structure. Higher t ...
Nike: Just Buy It (NYSE:NKE)
Seeking Alpha· 2026-02-23 15:47
So far in 2026, one of the biggest themes that has driven the stock market is a change of leadership. The tech and growth stocks that have driven much of the stock market’s gains over the past few years have retreated sharply, whileWith combined experience of covering technology companies on Wall Street and working in Silicon Valley, and serving as an outside adviser to several seed-round startups, Gary Alexander has exposure to many of the themes shaping the industry today. He has been a regular contributo ...
Stocks Gain as Court Blocks Tariffs; Yields Climb | The Close 2/20/2026
Youtube· 2026-02-21 00:23
Market Reaction - The S&P 500 increased by 0.5% following the Supreme Court ruling, with significant contributions from major tech stocks [2] - The average U.S. effective tariff rate was reduced from 13.6% to 6.5%, although this remains 4 percentage points higher than when Trump took office [3][4] - Investors are assessing the potential for refunds on over $170 billion in tariffs, which could impact stock prices significantly [4][39] Tariff Implications - The Supreme Court ruling indicates that President Trump exceeded his authority in imposing tariffs, which may lead to a reassessment of tariff policies [26][35] - The ruling could result in a refund process for businesses that paid unlawful tariffs, potentially affecting California's state government as well [29][32] - The uncertainty surrounding tariff refunds and future tariff implementations is expected to create a prolonged legal and economic process [20][76] Economic Impact - The tariffs have contributed to a significant increase in consumer prices, with estimates suggesting that 90% of the tariff costs are borne by U.S. consumers [54][71] - The ruling may lead to a budget deficit increase of approximately 0.6% of GDP, which could complicate the administration's economic agenda [63] - Companies are likely to face challenges in adjusting prices back to pre-tariff levels, as price increases tend to be sticky [72] Geopolitical Considerations - The potential for increased geopolitical tensions, particularly regarding Iran, could further complicate the economic landscape and impact market stability [56][57] - The administration's approach to tariffs may shift as it seeks alternative methods to impose tariffs, which could lead to further market volatility [20][50]
Stocks Whipsaw as Court Strikes Down Trump Tariffs
Youtube· 2026-02-20 18:20
Group 1 - The Supreme Court's recent ruling on tariffs is seen as a significant legal development, with implications for the political landscape and market reactions [1][3][4] - Historical context is provided, referencing past political struggles related to tariffs, particularly the impact on Republican seats in Congress due to public discontent with high prices [2] - The market response has been tepid, with the Dow only up by 40 points, indicating uncertainty among investors regarding the implications of the ruling [5][9] Group 2 - The ruling may lead to a reduction in tariffs, which have previously generated substantial revenue for the government, amounting to a quarter of a trillion dollars [11][12] - There is a discussion on the potential decrease in tariffs from a peak of 28% to current estimates of around 9%, reflecting a significant shift in trade policy [13][14] - The impact of tariffs on specific industries, such as baseball equipment, is highlighted, with mention of a 25% tariff on certain products affecting market dynamics [16][17]
Under Armour (UA) Surges 8.18% on Milestone Shoe Launch
Yahoo Finance· 2026-02-18 06:36
Core Viewpoint - Under Armour Inc. has experienced a significant stock rally following the launch of its final signature shoe under the Curry brand, indicating investor confidence despite recent financial challenges [1][2]. Group 1: Product Launch and Market Reaction - Under Armour launched the Curry 13, marking a significant moment in its partnership with NBA superstar Stephen Curry, which is set to end after more than a decade [2]. - The stock price of Under Armour increased by 8.18% to $7.54, reflecting renewed investor interest after the product launch [1]. Group 2: Financial Performance - In the third quarter of fiscal year 2026, Under Armour reported a net loss of $430.8 million, a stark contrast to a net income of $1.2 million in the same period the previous year [4]. - The company's net revenues decreased by 7% year-on-year, falling from $1.4 billion to $1.3 billion [4]. Group 3: Partnership Termination - Following the termination of the partnership, Stephen Curry retains all intellectual property rights, allowing him to potentially collaborate with other manufacturers in the future [3].
NIKE, Inc. Declares $0.41 Quarterly Dividend
Businesswire· 2026-02-13 22:00
Core Viewpoint - NIKE, Inc. has declared a quarterly cash dividend of $0.41 per share on its outstanding Class A and Class B Common Stock, indicating a commitment to returning value to shareholders [1] Dividend Announcement - The dividend is payable on April 1, 2026, to shareholders of record at the close of business on March 2, 2026 [1] Company Overview - NIKE, Inc. is headquartered near Beaverton, Oregon, and is recognized as the world's leading designer, marketer, and distributor of authentic athletic footwear, apparel, equipment, and accessories [1]
What Makes Nike (NKE) an Investment Bet?
Yahoo Finance· 2026-02-13 13:32
Core Viewpoint - Loomis Sayles Global Growth Fund emphasizes a focus on high-quality companies with competitive advantages and long-term growth potential, despite a negative return of -3.05% in Q4 2025 compared to a positive return of 3.29% for the MSCI ACWI Index Net [1]. Group 1: Fund Performance and Strategy - The Fund returned -3.05% in Q4 2025, underperforming the MSCI ACWI Index Net, which returned 3.29% [1]. - The Fund aims to capitalize on price dislocations by maintaining coverage of high-quality businesses [1]. Group 2: NIKE, Inc. Investment Insights - NIKE, Inc. (NYSE:NKE) was highlighted as a new addition to the Fund's portfolio, with a market capitalization of $90.45 billion [2]. - NIKE's stock closed at $61.10 per share on February 12, 2026, with a one-month return of -5.09% and a twelve-month decline of 16.35% [2]. - The investment thesis for NIKE includes a focus on quality, growth, and valuation, with the company being recognized as the largest premium-branded sportswear company globally [3]. Group 3: Hedge Fund Interest - NIKE, Inc. was held by 89 hedge fund portfolios at the end of Q3 2025, an increase from 81 in the previous quarter [4]. - Despite the interest, the company is not among the 30 most popular stocks among hedge funds, with some analysts suggesting that certain AI stocks may offer better upside potential [4].
Nike-owned Converse to realign operations and trim corporate workforce, source says
Reuters· 2026-02-13 00:09
Core Viewpoint - Nike-owned Converse is realigning its operations and reducing its corporate workforce to better align with its parent company's strategies aimed at recapturing sales growth [1] Group 1: Corporate Restructuring - Converse is cutting corporate roles and shifting many employees' responsibilities and reporting structures as part of a strategic overhaul [1] - Nearly all corporate employees at Converse will experience some level of change due to this restructuring [1] Group 2: Strategic Changes - The restructuring includes the formation of cross-functional teams focused on various sports, mirroring Nike's broader operational strategy [1] - This move follows previous layoffs at Nike, including 775 distribution roles cut in January, as part of efforts to boost profits and enhance automation [1] Group 3: Market Positioning - Under CEO Elliott Hill, Converse is attempting to regain market share lost to competitors, indicating a proactive approach to its market positioning [1] - The brand had previously implemented job cuts in May 2024 as part of a cost-saving initiative linked to its parent company's overall strategy [1]
Unusual Options Activity Alert: 3 Stocks Setting Up for Major Profit Potential
Yahoo Finance· 2026-02-06 18:35
分组1 - Analysts are divided on VF Corp (VFC) stock, with only three out of 22 rating it a Buy and a target price of $18.58, while the Barchart Technical Opinion suggests a Strong Buy for a more positive outlook [1] - VF Corp, known for brands like The North Face, Vans, and Timberland, is undergoing a turnaround involving divestitures and job cuts, with CEO Bracken Darrell leading the efforts since June 2023 [2] - VFC shares have increased by 13.3% year to date but have decreased by 75% over the past five years, indicating a significant long-term decline despite recent gains [2] 分组2 - The S&P 500 and Dow experienced losses of 1.23% and 1.20% respectively, while tech stocks also faced declines, highlighting a challenging market environment [6] - Pfizer's Q4 2025 results showed revenues of $17.56 billion, exceeding Wall Street's estimates, and earnings per share of $0.66, indicating a positive financial performance [15] - Pfizer's experimental weight-loss drug PF-08653944 is showing promising results in clinical trials, potentially positioning the company for recovery in the competitive pharmaceutical market [17]